Intercellular adhesion molecule-1 and gelatinase expression in human peritoneal mesothelial cells during propagation in culture

Translational Research

Volumn 153, Issue 5, 2009, Pages 240-248

  Sikkink, Cornelis J J M ^a   Reijnen, Michel M P J ^b   Duffhues, Bram A R ^c   de Man, Ben M ^c   Lomme, Roger M L M ^c   van Goor, Harry ^c  

^a Zuyderland Medical Centre   (Netherlands)

^b Alysis Zorggroep ^*  (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE; GELATINASE A; GELATINASE B; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; LIQUID NITROGEN; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL LINEAGE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZING; HUMAN; HUMAN CELL; MESOTHELIUM CELL; OMENTUM; PERITONEUM; PERITONEUM LAVAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REPAIR; ZYMOGRAPHY;

EID: 64249108992     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2009.01.003     Document Type: Article

References (35)

1. Mutsaers S.E. The mesothelial cell. Int J Biochem Cell Biol 36 (2004) 9-16
2. Holmdahl L., and Ivarsson M.L. The role of cytokines, coagulation, and fibrinolysis in peritoneal tissue repair. Eur J Surg 165 (1999) 1012-1019
3. Bittinger F., Schepp C., Brochhausen C., et al. Remodeling of peritoneal-like structures by mesothelial cells: its role in peritoneal healing. J Surg Res 82 (1999) 28-33
4. Yao V., Platell C., and Hall J.C. Role of peritoneal mesothelial cells in peritonitis. Br J Surg 90 (2003) 1187-1194
5. Liberek T., Topley N., Luttmann W., and Williams J.D. Adherence of neutrophils to human peritoneal mesothelial cells: role of intercellular adhesion molecule-1. J Am Soc Nephrol 7 (1996) 208-217
6. Ma C., Tarnuzzer R.W., and Chegini N. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-β1. Wound Repair Regen 7 (1999) 477-485
7. Martin J., Yung S., Robson R.L., Steadman R., and Davies M. Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Perit Dial Int 20 (2000) 524-533
8. Wu F.P., Sietses C., von Blomberg B.M., van Leeuwen P.A., Meijer S., and Cuesta M.A. Systemic and peritoneal inflammatory response after laparoscopic or conventional colon resection in cancer patients: a prospective, randomized trial. Dis Colon Rectum 46 (2003) 147-155
9. Decker D., Tolba R., Springer W., Lauschke H., Hirner A., and von Ruecker A. Abdominal surgical interventions: local and systemic consequences for the immune system-a prospective study on elective gastrointestinal surgery. J Surg Res 126 (2005) 12-18
10. Ivarsson M.L., Holmdahl L., Falk P., Mölne J., and Risberg B. Characterization and fibrinolytic properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest 58 (1998) 195-203
11. Lucidi R.S., Witz C.A., Chrisco M., Binkley P.A., Shain S.A., and Schenken R.S. A novel in vitro model of the early endometriotic lesion demonstrates that attachment of endometrial cells to mesothelial cells is dependent on the source of endometrial cells. Fertil Steril 84 (2005) 16-21
12. Ponzin D., Vecchia P., Toffano G., Giordano C., and Bruni A. Characterization of macrophages elicited by intra-peritoneal injection of hyaluronate. Agents Actions 18 (1986) 544-549
13. Suzuki Y., and Yamguchi T. Effects of hyaluronic acid on the macrophage phagocytosis and active oxygen release. Agents Actions 38 (1993) 32-37
14. Akatsuka M., Yamamoto Y., Tobetto K., Yasui T., and Ando T. Suppressive effects of hyaluronic acid on elastase release from rat peritoneal leucocytes. J Pharm Pharmacol 45 (1993) 110-114
15. Fraser J.R.E., Laurent T.C., and Laurent U.B.G. Hyaluronan: it's nature, distribution and turnover. J Int Med 242 (1997) 23-77
16. Becker J.M., Dayton M.T., Fazio V.W., et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective randomized, double-blind multicenter study. J Am Coll Surg 183 (1996) 297-306
17. Burns J.W., Skinner K., Colt J., et al. Prevention of tissue injury and postoperative adhesions by precoating tissues with Hyaluronic acid solutions. J Surg Res 59 (1995) 644-652
18. Diamond M.P. Reduction of de novo postsurgical adhesions by intraoperative precoating with Sepracoat* (HAL-C) solution: a prospective, randomised, blinded, placebo-controlled multicenter study. Fertil Steril 69 (1998) 1067-1074
19. Diamond M.P. Reduction of adhesions after uterine myomectomy by seprafilm membrane (HA-F): a blinded, randomised multicenter clinical study. Fertil Steril 66 (1996) 904-910
20. Nooteboom A., van der Linden C.J., and Hendriks T. Modulation of adhesion molecule expression on endothelial cells after induction by lipopolysaccharide-stimulated whole blood. Scand J Immunol 59 (2004) 440-448
21. Waas E.T., Lomme R.M.L.M., DeGroot J., Wobbes T., and Hendriks T. Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer. Br J Cancer 86 (2002) 1876-1883
22. Reijnen M.M., Bleichrodt R.P., and van Goor H. Pathophysiology of intra-abdominal adhesion and abscess formation, and the effect of hyaluronan. Br J Surg 90 (2003) 533-541
23. Foley-Comer A.J., Herrick S.E., Al-Mishlab T., Prêle C.M., Laurent G.J., and Mutsaers S.E. Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci 115 (2002) 1383-1389
24. Hausmann M.J., Rogachev B., Weiler M., Chaimovitz C., and Douvdevani A. Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth. Kidney Int 57 (2000) 476-486
25. Johkura K., Liang Y., Cui L., Ogiwara N., and Sasaki K. Spatial distribution of cell adhesion molecules on the peritoneal surface in the cecal perforation-induced peritonitis. Anat Rec 264 (2001) 219-227
26. Ziprin P., Ridgway P.F., Pfistermuller K.L., Peck D.H., and Darzi A.W. ICAM-1 mediated tumor-mesothelial cell adhesion is modulated by IL-6 and TNF-alpha: a potential mechanism by which surgical trauma increases peritoneal metastases. Cell Commun Adhes 10 (2003) 141-154
27. Marshall B.C., Santana A., Xu Q.P., et al. Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. J Clin Invest 91 (1993) 1792-1799
28. Rougier J.P., Moullier P., Piedagnel R., and Ronco P.M. Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells. Kidney Int 51 (1997) 337-347
29. Martin J., Yung S., Robson R.L., Steadman R., and Davies M. Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Perit Dial Int 20 (2000) 524-533
30. Horiuchi T., Miyamoto K., Miyamoto S., et al. Image analysis of remesothelialization following chemical wounding of cultured human peritoneal mesothelial cells: the role of hyaluronan synthesis. Kidney Int 64 (2003) 2280-2290
31. Reijnen M.M., van Goor H., Falk P., Hedgren M., and Holmdahl L. Sodium hyaluronate increases the fibrinolytic response of human peritoneal mesothelial cells exposed to tumor necrosis factor alpha. Arch Surg 136 (2001) 291-296
32. Sikkink C.J., Reijnen M.M., Falk P., van Goor H., and Holmdahl L. Influence of monocyte-like cells on the fibrinolytic activity of peritoneal mesothelial cells and the effect of sodium hyaluronate. Fertil Steril 84 (2005) 1072-1077
33. Habara T., Nakatsuka M., Konishi H., Asagiri K., Noguchi S., and Kudo T. The biological effects of antiadhesion agents on activated RAW264.7 macrophages. J Biomed Mater Res 61 (2002) 628-633
34. Alaniz L., Garcia M., Cabrera P., et al. Modulation of matrix metalloproteinase-9 activity by hyaluronan is dependent on NF-kappaB activity in lymphoma cell lines with dissimilar invasive behavior. Biochem Biophys Res Commun 324 (2004) 736-743
35. Alkhamesi N.A., Ziprin P., Pfistermuller K., Peck D.H., and Darzi A.W. ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention. Clin Exp Metastasis 22 (2005) 449-459